# Alzex Neuropharma Inc. (TRRI)

> Basic Materials · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TRRI/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -90.0K | N/A | $ 117.1K | $ -559.6K |
| 2023 | $ 0 | $ -182.2K | $ -9.8K | $ 99.3K | $ -386.7K |
| 2022 | $ 0 | $ -185.5K | $ -98.5K | $ 91.2K | $ -218.1K |
| 2021 | $ 0 | $ -28.1K | N/A | $ 45.2K | $ -98.3K |
| 2020 | $ 0 | $ -955 | N/A | N/A | N/A |
| 2013 | $ 0 | $ -103.3K | $ -78.1K | $ 217.0K | $ -203.4K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.21 |
| Liabilities / Eq | -1.01 |
| Current Ratio | 0.01 |

## Other views

- [Metrics](https://sponda.capital/en/TRRI.md)
- [Charts](https://sponda.capital/en/TRRI/charts.md)
- [Compare](https://sponda.capital/en/TRRI/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.